FrançaisParis, France and Camberley, UK – 6 November 2019 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it has agreed a €5.0m four-year term loan. The funds will be used for the repayment of certain outstanding loans, working capital and the immediate settlement of its entire convertible bond facility. http://novacyt.com/wp-content/uploads/2019/11/Novacyt-Refinancing-PR-ENG.pdf
Visit PageCategory: Uncategorized
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 November 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is
Visit PageINFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2019/10/NOVACYT_CP_Droits-de-vote_2019-Oct-2019.pdf
Visit Page